Glycobiarsol
![]() | |
![]() | |
Names | |
---|---|
IUPAC name
Glycobiarsol | |
Systematic IUPAC name
Oxobismuthanyl hydrogen [4-(2-hydroxyacetamido)phenyl]arsonate | |
Other names
[4-[(2-Hydroxyacetyl)amino]phenyl]-oxobismuthanyl-oxyarsinic acid | |
Identifiers | |
116-49-4 ![]() | |
ChemSpider | 10669861 ![]() |
EC Number | 204-143-1 |
Jmol interactive 3D | Image |
KEGG | D07358 |
PubChem | 16682839 |
UNII | E3U8347QWJ ![]() |
| |
| |
Properties | |
C8H9AsBiNO6 | |
Molar mass | 499.06 g·mol−1 |
Pharmacology | |
ATC code | P01 QP51AD03 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Glycobiarsol (trade name Milibis) is an antiprotozoal agent that has been used in humans[1] as well as in dogs.[2]
References
- ↑ Berberian, D. A. (1954). "The trichomonacidal activity of milibis (glycobiarsol)". New York state journal of medicine 54 (22): 3102–3105. PMID 13214428.
- ↑ Kibble, R. M. (1969). "Glycobiarsol for the control of Trichuris vulpis infection in the dog". Australian Veterinary Journal 45 (8): 387. PMID 5389346.
|
This article is issued from Wikipedia - version of the Sunday, January 31, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.